vs
MESA LABORATORIES INC（MLAB）与合众银行（WASH）财务数据对比。点击上方公司名可切换其他公司
MESA LABORATORIES INC的季度营收约是合众银行的1.1倍（$65.1M vs $57.8M），合众银行净利率更高（21.8% vs 5.6%，领先16.2%），过去两年合众银行的营收复合增速更高（9.5% vs 5.1%）
梅萨实验室有限公司开发、生产和销售专业质控、校准及监测仪器与配套服务，核心业务覆盖医疗健康、制药、食品饮料、工业卫生及环境检测领域，为全球客户满足合规及运营安全需求提供支持。
美国合众银行是一家美国跨国金融机构，总部位于明尼苏达州明尼阿波利斯，在特拉华州注册成立。截至2025年，该银行为美国第五大银行，也是美国中西部规模最大的银行，被金融稳定委员会认定为具有系统重要性的金融机构。它主营银行、投资、抵押贷款等多元金融业务。
MLAB vs WASH — 直观对比
营收规模更大
MLAB
是对方的1.1倍
$57.8M
净利率更高
WASH
高出16.2%
5.6%
两年增速更快
WASH
近两年复合增速
5.1%
损益表 — Q3 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $65.1M | $57.8M |
| 净利润 | $3.6M | $12.6M |
| 毛利率 | 64.2% | — |
| 营业利润率 | 12.2% | — |
| 净利率 | 5.6% | 21.8% |
| 营收同比 | 3.6% | — |
| 净利润同比 | 316.6% | 3.5% |
| 每股收益（稀释后） | $0.65 | $0.66 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MLABWASH
| Q1 26 | — | $57.8M | ||
| Q4 25 | $65.1M | $59.3M | ||
| Q3 25 | $60.7M | $56.5M | ||
| Q2 25 | $59.5M | $54.3M | ||
| Q1 25 | $62.1M | $59.1M | ||
| Q4 24 | $62.8M | $12.4M | ||
| Q3 24 | $57.8M | $48.5M | ||
| Q2 24 | $58.2M | $48.2M |
净利润MLABWASH
| Q1 26 | — | $12.6M | ||
| Q4 25 | $3.6M | $16.0M | ||
| Q3 25 | $2.5M | $10.8M | ||
| Q2 25 | $4.7M | $13.2M | ||
| Q1 25 | $-7.1M | $12.2M | ||
| Q4 24 | $-1.7M | $-60.8M | ||
| Q3 24 | $3.4M | $11.0M | ||
| Q2 24 | $3.4M | $10.8M |
毛利率MLABWASH
| Q1 26 | — | — | ||
| Q4 25 | 64.2% | — | ||
| Q3 25 | 61.5% | — | ||
| Q2 25 | 62.0% | — | ||
| Q1 25 | 61.8% | — | ||
| Q4 24 | 63.3% | — | ||
| Q3 24 | 61.3% | — | ||
| Q2 24 | 64.0% | — |
营业利润率MLABWASH
| Q1 26 | — | — | ||
| Q4 25 | 12.2% | 34.9% | ||
| Q3 25 | 7.8% | 24.7% | ||
| Q2 25 | 5.1% | 31.6% | ||
| Q1 25 | 2.4% | 26.5% | ||
| Q4 24 | 9.2% | -648.7% | ||
| Q3 24 | 6.1% | 28.5% | ||
| Q2 24 | 9.6% | 28.7% |
净利率MLABWASH
| Q1 26 | — | 21.8% | ||
| Q4 25 | 5.6% | 27.0% | ||
| Q3 25 | 4.1% | 19.2% | ||
| Q2 25 | 8.0% | 24.4% | ||
| Q1 25 | -11.4% | 20.6% | ||
| Q4 24 | -2.7% | -491.4% | ||
| Q3 24 | 5.9% | 22.6% | ||
| Q2 24 | 5.8% | 22.4% |
每股收益（稀释后）MLABWASH
| Q1 26 | — | $0.66 | ||
| Q4 25 | $0.65 | $0.84 | ||
| Q3 25 | $0.45 | $0.56 | ||
| Q2 25 | $0.85 | $0.68 | ||
| Q1 25 | $-1.30 | $0.63 | ||
| Q4 24 | $-0.31 | $-3.54 | ||
| Q3 24 | $0.63 | $0.64 | ||
| Q2 24 | $0.62 | $0.63 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $29.0M | $12.3M |
| 总债务越低越好 | $68.4M | — |
| 股东权益账面价值 | $186.7M | $546.8M |
| 总资产 | $434.8M | $6.5B |
| 负债/权益比越低杠杆越低 | 0.37× | — |
8季度趋势，按日历期对齐
现金及短期投资MLABWASH
| Q1 26 | — | $12.3M | ||
| Q4 25 | $29.0M | — | ||
| Q3 25 | $20.4M | — | ||
| Q2 25 | $21.3M | — | ||
| Q1 25 | $27.3M | — | ||
| Q4 24 | $27.3M | — | ||
| Q3 24 | $24.3M | — | ||
| Q2 24 | $28.5M | — |
总债务MLABWASH
| Q1 26 | — | — | ||
| Q4 25 | $68.4M | — | ||
| Q3 25 | $69.4M | — | ||
| Q2 25 | $70.3M | — | ||
| Q1 25 | $71.3M | — | ||
| Q4 24 | $72.2M | — | ||
| Q3 24 | $73.1M | — | ||
| Q2 24 | $74.1M | — |
股东权益MLABWASH
| Q1 26 | — | $546.8M | ||
| Q4 25 | $186.7M | $543.6M | ||
| Q3 25 | $178.5M | $533.0M | ||
| Q2 25 | $172.5M | $527.5M | ||
| Q1 25 | $159.8M | $521.7M | ||
| Q4 24 | $155.2M | $499.7M | ||
| Q3 24 | $161.5M | $502.2M | ||
| Q2 24 | $150.7M | $471.0M |
总资产MLABWASH
| Q1 26 | — | $6.5B | ||
| Q4 25 | $434.8M | $6.6B | ||
| Q3 25 | $430.4M | $6.7B | ||
| Q2 25 | $435.7M | $6.7B | ||
| Q1 25 | $433.3M | $6.6B | ||
| Q4 24 | $433.3M | $6.9B | ||
| Q3 24 | $454.1M | $7.1B | ||
| Q2 24 | $440.4M | $7.2B |
负债/权益比MLABWASH
| Q1 26 | — | — | ||
| Q4 25 | 0.37× | — | ||
| Q3 25 | 0.39× | — | ||
| Q2 25 | 0.41× | — | ||
| Q1 25 | 0.45× | — | ||
| Q4 24 | 0.47× | — | ||
| Q3 24 | 0.45× | — | ||
| Q2 24 | 0.49× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $18.8M | — |
| 自由现金流经营现金流 - 资本支出 | $18.0M | — |
| 自由现金流率自由现金流/营收 | 27.7% | — |
| 资本支出强度资本支出/营收 | 1.1% | — |
| 现金转化率经营现金流/净利润 | 5.17× | — |
| 过去12个月自由现金流最近4个季度 | $37.9M | — |
8季度趋势，按日历期对齐
经营现金流MLABWASH
| Q1 26 | — | — | ||
| Q4 25 | $18.8M | $80.3M | ||
| Q3 25 | $8.2M | $39.6M | ||
| Q2 25 | $1.9M | $11.3M | ||
| Q1 25 | $12.7M | $8.4M | ||
| Q4 24 | $18.1M | $57.7M | ||
| Q3 24 | $5.3M | $25.7M | ||
| Q2 24 | $10.7M | $11.2M |
自由现金流MLABWASH
| Q1 26 | — | — | ||
| Q4 25 | $18.0M | $78.3M | ||
| Q3 25 | $7.1M | $39.3M | ||
| Q2 25 | $884.0K | $10.9M | ||
| Q1 25 | $11.9M | $8.4M | ||
| Q4 24 | $17.3M | $53.7M | ||
| Q3 24 | $3.5M | $24.4M | ||
| Q2 24 | $9.9M | $9.6M |
自由现金流率MLABWASH
| Q1 26 | — | — | ||
| Q4 25 | 27.7% | 132.2% | ||
| Q3 25 | 11.7% | 69.6% | ||
| Q2 25 | 1.5% | 20.2% | ||
| Q1 25 | 19.2% | 14.2% | ||
| Q4 24 | 27.6% | 433.8% | ||
| Q3 24 | 6.0% | 50.4% | ||
| Q2 24 | 16.9% | 19.8% |
资本支出强度MLABWASH
| Q1 26 | — | — | ||
| Q4 25 | 1.1% | 3.4% | ||
| Q3 25 | 1.8% | 0.6% | ||
| Q2 25 | 1.7% | 0.7% | ||
| Q1 25 | 1.2% | 0.1% | ||
| Q4 24 | 1.3% | 32.3% | ||
| Q3 24 | 3.1% | 2.6% | ||
| Q2 24 | 1.5% | 3.4% |
现金转化率MLABWASH
| Q1 26 | — | — | ||
| Q4 25 | 5.17× | 5.03× | ||
| Q3 25 | 3.32× | 3.65× | ||
| Q2 25 | 0.40× | 0.86× | ||
| Q1 25 | — | 0.69× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.54× | 2.34× | ||
| Q2 24 | 3.17× | 1.03× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MLAB
| Sterilization And Disinfection Control | $24.9M | 38% |
| Biopharmaceutical Development | $14.4M | 22% |
| Other | $14.1M | 22% |
| Clinical Genomics | $11.8M | 18% |
WASH
| Net Interest Income | $40.5M | 70% |
| Noninterest Income | $17.3M | 30% |
